BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaik N, Giri N, Elmquist WF. Investigation of the micellar effect of pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies. J Pharm Sci 2009;98:4170-90. [PMID: 19283769 DOI: 10.1002/jps.21723] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Toscanini MA, Limeres MJ, Garrido AV, Cagel M, Bernabeu E, Moretton MA, Chiappetta DA, Cuestas ML. Polymeric micelles and nanomedicines: Shaping the future of next generation therapeutic strategies for infectious diseases. Journal of Drug Delivery Science and Technology 2021;66:102927. [DOI: 10.1016/j.jddst.2021.102927] [Reference Citation Analysis]
2 Brugués AP, Naveros BC, Calpena Campmany AC, Pastor PH, Saladrigas RF, Lizandra CR. Developing cutaneous applications of paromomycin entrapped in stimuli-sensitive block copolymer nanogel dispersions. Nanomedicine (Lond) 2015;10:227-40. [PMID: 25600968 DOI: 10.2217/nnm.14.102] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
3 Wei Z, Yuan S, Hao J, Fang X. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity. Eur J Pharm Biopharm 2013;83:266-74. [PMID: 23089310 DOI: 10.1016/j.ejpb.2012.09.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
4 Sosnik A. Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing "Generally Recognized As Safe" (GRAS) nanopharmaceuticals: A review. Adv Drug Deliv Rev 2013;65:1828-51. [PMID: 24055628 DOI: 10.1016/j.addr.2013.09.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
5 Sanderson L, da Silva M, Sekhar GN, Brown RC, Burrell-Saward H, Fidanboylu M, Liu B, Dailey LA, Dreiss CA, Lorenz C, Christie M, Persaud SJ, Yardley V, Croft SL, Valero M, Thomas SA. Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug. PLoS Negl Trop Dis 2021;15:e0009276. [PMID: 33857146 DOI: 10.1371/journal.pntd.0009276] [Reference Citation Analysis]
6 Sane R, Mittapalli RK, Elmquist WF. Development and evaluation of a novel microemulsion formulation of elacridar to improve its bioavailability. J Pharm Sci 2013;102:1343-54. [PMID: 23334925 DOI: 10.1002/jps.23450] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
7 Yin Q, Shen J, Zhang Z, Yu H, Chen L, Gu W, Li Y. Multifunctional Nanoparticles Improve Therapeutic Effect for Breast Cancer by Simultaneously Antagonizing Multiple Mechanisms of Multidrug Resistance. Biomacromolecules 2013;14:2242-52. [DOI: 10.1021/bm400378x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
8 Husain A, Makadia V, Valicherla GR, Riyazuddin M, Gayen JR. Approaches to minimize the effects of P-glycoprotein in drug transport: A review. Drug Dev Res 2022. [PMID: 35103340 DOI: 10.1002/ddr.21918] [Reference Citation Analysis]
9 Shah MR, Imran M, Ullah S. Nanosuspensions. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis. Elsevier; 2017. pp. 139-72. [DOI: 10.1016/b978-0-323-52729-3.00005-6] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Vasconcelos T, Marques S, Sarmento B. The biopharmaceutical classification system of excipients. Therapeutic Delivery 2017;8:65-78. [DOI: 10.4155/tde-2016-0067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
11 Houang EM, Sham YY, Bates FS, Metzger JM. Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers. Skelet Muscle 2018;8:31. [PMID: 30305165 DOI: 10.1186/s13395-018-0177-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
12 Seremeta KP, Chiappetta DA, Sosnik A. Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz. Colloids Surf B Biointerfaces 2013;102:441-9. [PMID: 23010128 DOI: 10.1016/j.colsurfb.2012.06.038] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
13 Sosnik A, Chiappetta DA, Carcaboso ÁM. Drug delivery systems in HIV pharmacotherapy: What has been done and the challenges standing ahead. Journal of Controlled Release 2009;138:2-15. [DOI: 10.1016/j.jconrel.2009.05.007] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 6.2] [Reference Citation Analysis]
14 Raveendran R, Mullen KM, Wellard RM, Sharma CP, Hoogenboom R, Dargaville TR. Poly(2-oxazoline) block copolymer nanoparticles for curcumin loading and delivery to cancer cells. European Polymer Journal 2017;93:682-94. [DOI: 10.1016/j.eurpolymj.2017.02.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
15 Chiappetta DA, Hocht C, Opezzo JA, Sosnik A. Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV. Nanomedicine (Lond). 2013;8:223-237. [PMID: 23173734 DOI: 10.2217/nnm.12.104] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
16 Taşlı PN, Yalvaç ME, Sofiev N, Şahin F. Effect of F68, F127, and P85 Pluronic Block Copolymers on Odontogenic Differentiation of Human Tooth Germ Stem Cells. Journal of Endodontics 2013;39:1265-71. [DOI: 10.1016/j.joen.2013.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
17 Alvarez-lorenzo C, Rey-rico A, Brea J, Loza MI, Concheiro A, Sosnik A. Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives. Nanomedicine 2010;5:1371-83. [DOI: 10.2217/nnm.10.53] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
18 Zhang W, Li Y, Zou P, Wu M, Zhang Z, Zhang T. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update. AAPS J 2016;18:830-43. [PMID: 27184579 DOI: 10.1208/s12248-016-9928-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]